All In MedTech

Device Trial Radar · NCT02539069

The Post-marketing Surveillance to Evaluate the Efficacy of CHONDRON (Autologous Cultured Chondrocyte) by Arthroscopy

A Post-marketing Surveillance to Evaluate the Efficacy and Safety of CHONDRON (Autologous Cultured Chondrocyte) Through Arthroscopy in Patients With Knee Cartilage Defects

Last checked: Nov 19, 2026Latest source record: Apr 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

10

Actual

Start

Oct 23, 2012

Primary completion

Jan 15, 2016

Study completion Jan 15, 2016

Sponsor

Lead sponsor
Cellontech Co., Ltd.Not on our public-company list
Sponsor type
Industry
First posted
Sep 2, 2015

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Primary purpose
Treatment
Who can join
All sexes, from 15 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

A clinical trial to evaluate the long-term efficacy and safety of Chondron (Autologous cultured Chondrocyte) administered through arthroscopy from the drug's 48 weeks efficacy and safety evaluation with 96 weeks follow-up in patients with knee cartilage defects.

Conditions

  • Osteoarthritis
  • Traumatic Arthritis

Interventions

  • Chondron ImplantationDevice

    In one vial (0.4 ml), Main ingredient: 1.2 million or more autologous chondrocytes Culture solution: Adequate amount of Dulbecco's modified Eagle medium (DMEM) The cells that fill the vial are sufficiently suspended, and a sufficient amount of suspension is grafted in the defect with fibrin glue.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. change in pain of 100mm Visual Analog ScaleTime frame: 48 weeks after the surgery

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Yonsei University Severance Hospital

    Seoul, Seoul, South Korea

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.